UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 134

Sortiert nach

Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications

Frontiers in oncology, 2018-02, Vol.8, p.24-24

2018

Volltextzugriff (PDF)

DNA Methylation Readers and Cancer: Mechanistic and Therapeutic Applications

Frontiers in oncology, 2019-06, Vol.9, p.489-489

2019

Volltextzugriff (PDF)

Role of Methylation in Pro- and Anti-Cancer Immunity

Cancers, 2021-02, Vol.13 (3), p.545

2021

Volltextzugriff (PDF)

Fibrinolytic System and Cancer: Diagnostic and Therapeutic Applications

International journal of molecular sciences, 2021-04, Vol.22 (9), p.4358

2021

Volltextzugriff (PDF)

Methyl-CpG binding domain protein 2 (Mbd2) drives breast cancer progression through the modulation of epithelial-to-mesenchymal transition

Experimental & molecular medicine, 2024-04, Vol.56 (4), p.959-974

2024

Volltextzugriff (PDF)

DNA methylation signatures of Prostate Cancer in peripheral T-cells

BMC cancer, 2020-06, Vol.20 (1), p.588-588, Article 588

2020

Volltextzugriff (PDF)

Co-Targeting Luminal B Breast Cancer with S-Adenosylmethionine and Immune Checkpoint Inhibitor Reduces Primary Tumor Growth and Progression, and Metastasis to Lungs and Bone

Cancers, 2022-12, Vol.15 (1), p.48

2022

Volltextzugriff (PDF)

DNA methylation signatures of breast cancer in peripheral T-cells

BMC cancer, 2018-05, Vol.18 (1), p.574-574, Article 574

2018

Volltextzugriff (PDF)

Expression of RANKL/RANK/OPG in primary and metastatic human prostate cancer as markers of disease stage and functional regulation

Cancer, 2006-07, Vol.107 (2), p.289-298

2006

Volltextzugriff (PDF)

Alteration of the methylation status of tumor-promoting genes decreases prostate cancer cell invasiveness and tumorigenesis in vitro and in vivo

Cancer research (Chicago, Ill.), 2006-09, Vol.66 (18), p.9202-9210

2006

Volltextzugriff (PDF)

Pharmacological Inhibition of DNA Methylation Induces Proinvasive and Prometastatic Genes In Vitro and In Vivo

Neoplasia (New York, N.Y.), 2008-03, Vol.10 (3), p.266-278

2008

Volltextzugriff (PDF)

Methyl-CpG binding domain 2 (Mbd2) is an epigenetic regulator of autism-risk genes and cognition

Translational psychiatry, 2023-07, Vol.13 (1), p.259-259, Article 259

2023

Volltextzugriff (PDF)

Reversal of the Hypomethylation Status of Urokinase (uPA) Promoter Blocks Breast Cancer Growth and Metastasis

The Journal of biological chemistry, 2004-07, Vol.279 (30), p.31735-31744

2004

Volltextzugriff (PDF)

An Anti-Urokinase Plasminogen Activator Receptor Antibody (ATN-658) Blocks Prostate Cancer Invasion, Migration, Growth, and Experimental Skeletal Metastasis In Vitro and In Vivo

Neoplasia (New York, N.Y.), 2010-10, Vol.12 (10), p.778-788

2010

Volltextzugriff (PDF)

uPAR antibody (huATN-658) and Zometa reduce breast cancer growth and skeletal lesions

Bone research, 2020-04, Vol.8 (1), p.18-18

2020

Volltextzugriff (PDF)

A non–RGD-based integrin binding peptide (ATN-161) blocks breast cancer growth and metastasis in vivo

Molecular cancer therapeutics, 2006-09, Vol.5 (9), p.2271-2280

2006

Volltextzugriff (PDF)

SKI-606 (Bosutinib) blocks prostate cancer invasion, growth, and metastasis in vitro and in vivo through regulation of genes involved in cancer growth and skeletal metastasis

Molecular cancer therapeutics, 2010-05, Vol.9 (5), p.1147-1157

2010

Volltextzugriff (PDF)

LRP5 knockdown: effect on prostate cancer invasion growth and skeletal metastasis in vitro and in vivo

Cancer medicine (Malden, MA), 2013-10, Vol.2 (5), p.625-635

2013

Volltextzugriff (PDF)

Erratum to: A novel function for p21 Cip1 and acetyltransferase p/CAF as critical transcriptional regulators of TGFβ-mediated breast cancer cell migration and invasion

Breast cancer research : BCR, 2017-03, Vol.19 (1), p.40-40, Article 40

2017

Volltextzugriff (PDF)

S‐adenosylmethionine in combination with decitabine shows enhanced anti‐cancer effects in repressing breast cancer growth and metastasis

Journal of cellular and molecular medicine, 2020-09, Vol.24 (18), p.10322-10337

2020

Volltextzugriff (PDF)

Methylation status of uPA promoter as a molecular mechanism regulating prostate cancer invasion and growth in vitro and in vivo

The FASEB journal, 2003-06, Vol.17 (9), p.1081-1088

2003

Volltextzugriff (PDF)

Identification of an Epigenetic Signature of Osteoporosis in Blood DNA of Postmenopausal Women

Journal of bone and mineral research, 2021-11, Vol.36 (11), p.2285-2286

2021

Volltextzugriff (PDF)

Epigenomic effects of vitamin D in colorectal cancer

Epigenomics, 2022-10, Vol.14 (19), p.1213-1228

2022

Volltextzugriff (PDF)

Demethylation of Urokinase Promoter as a Prognostic Marker in Patients with Breast Carcinoma

Clinical cancer research, 2004-05, Vol.10 (9), p.3035-3041

2004

Volltextzugriff (PDF)

Methyl donor S-adenosylmethionine (SAM) supplementation attenuates breast cancer growth, invasion, and metastasis in vivo ; therapeutic and chemopreventive applications

Oncotarget, 2018-01, Vol.9 (4), p.5169-5183

2018

Volltextzugriff (PDF)

1 – 25 von 134

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(130)
Mit Volltextzugriff
(125)

Publikationsform

Artikel
(133)
Buchkapitel
(1)

Sprache

Englisch
(134)
Japanisch
(26)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications

DNA Methylation Readers and Cancer: Mechanistic and Therapeutic Applications

Role of Methylation in Pro- and Anti-Cancer Immunity

Fibrinolytic System and Cancer: Diagnostic and Therapeutic Applications

Methyl-CpG binding domain protein 2 (Mbd2) drives breast cancer progression through the modulation of epithelial-to-mesenchymal transition

DNA methylation signatures of Prostate Cancer in peripheral T-cells

Co-Targeting Luminal B Breast Cancer with S-Adenosylmethionine and Immune Checkpoint Inhibitor Reduces Primary Tumor Growth and Progression, and Metastasis to Lungs and Bone

DNA methylation signatures of breast cancer in peripheral T-cells

Expression of RANKL/RANK/OPG in primary and metastatic human prostate cancer as markers of disease stage and functional regulation

Alteration of the methylation status of tumor-promoting genes decreases prostate cancer cell invasiveness and tumorigenesis in vitro and in vivo

Pharmacological Inhibition of DNA Methylation Induces Proinvasive and Prometastatic Genes In Vitro and In Vivo

Methyl-CpG binding domain 2 (Mbd2) is an epigenetic regulator of autism-risk genes and cognition

Reversal of the Hypomethylation Status of Urokinase (uPA) Promoter Blocks Breast Cancer Growth and Metastasis

An Anti-Urokinase Plasminogen Activator Receptor Antibody (ATN-658) Blocks Prostate Cancer Invasion, Migration, Growth, and Experimental Skeletal Metastasis In Vitro and In Vivo

uPAR antibody (huATN-658) and Zometa reduce breast cancer growth and skeletal lesions

A non–RGD-based integrin binding peptide (ATN-161) blocks breast cancer growth and metastasis in vivo

SKI-606 (Bosutinib) blocks prostate cancer invasion, growth, and metastasis in vitro and in vivo through regulation of genes involved in cancer growth and skeletal metastasis

LRP5 knockdown: effect on prostate cancer invasion growth and skeletal metastasis in vitro and in vivo

Erratum to: A novel function for p21 Cip1 and acetyltransferase p/CAF as critical transcriptional regulators of TGFβ-mediated breast cancer cell migration and invasion

S‐adenosylmethionine in combination with decitabine shows enhanced anti‐cancer effects in repressing breast cancer growth and metastasis

Methylation status of uPA promoter as a molecular mechanism regulating prostate cancer invasion and growth in vitro and in vivo

Identification of an Epigenetic Signature of Osteoporosis in Blood DNA of Postmenopausal Women

Epigenomic effects of vitamin D in colorectal cancer

Demethylation of Urokinase Promoter as a Prognostic Marker in Patients with Breast Carcinoma

Methyl donor S-adenosylmethionine (SAM) supplementation attenuates breast cancer growth, invasion, and metastasis in vivo ; therapeutic and chemopreventive applications

Suchergebnisse filtern